Similar effectiveness with primary HPV and cytology screening - Long-term follow-up of randomized cervical cancer screening trial
Open Access
- 12 December 2023
- journal article
- research article
- Published by Elsevier in Gynecologic Oncology
- Vol. 180, 146-151
Abstract
No abstract availableKeywords
Funding Information
- Syöpäsäätiö (190101)
This publication has 25 references indexed in Scilit:
- Detection rates of precancerous and cancerous cervical lesions within one screening round of primary human papillomavirus DNA testing: prospective randomised trial in FinlandBMJ, 2012
- The HPV test has similar sensitivity but more overdiagnosis than the Pap test—A randomised health services study on cervical cancer screening in FinlandInternational Journal of Cancer, 2012
- Human papillomavirus testing for the detection of high-grade cervical intraepithelial neoplasia and cancer: final results of the POBASCAM randomised controlled trialThe Lancet Oncology, 2012
- Efficacy of human papillomavirus testing for the detection of invasive cervical cancers and cervical intraepithelial neoplasia: a randomised controlled trialThe Lancet Oncology, 2010
- Low Proportion of False-Negative Smears in the Finnish Program for Cervical Cancer ScreeningCancer Epidemiology, Biomarkers & Prevention, 2010
- Age-Specific Evaluation of Primary Human Papillomavirus Screening vs Conventional Cytology in a Randomized SettingJNCI: Journal of the National Cancer Institute, 2009
- HPV Screening for Cervical Cancer in Rural IndiaNew England Journal of Medicine, 2009
- Human Papillomavirus and Papanicolaou Tests to Screen for Cervical CancerNew England Journal of Medicine, 2007
- Routine cervical screening with primary HPV testing and cytology triage protocol in a randomised settingBritish Journal of Cancer, 2005
- A Class of $K$-Sample Tests for Comparing the Cumulative Incidence of a Competing RiskThe Annals of Statistics, 1988